Juno Therapeutics, Inc.
Get Full AccessDescription
- Juno Therapeutics is building a fully integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer. Founded on the vision that the use of human cells as therapeutic entities will drive one of the next important phases in medicine, Juno is developing cell-based cancer immunotherapies based on chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to recognize and kill cancer. Juno is developing multiple cell-based product candidates to treat a variety of B-cell malignancies as well as solid tumors. Several product candidates have shown compelling evidence of tumor shrinkage in clinical trials in refractory leukemia and lymphoma conducted to date. Juno's long-term aim is to leverage its cell-based platform to develop new product candidates that address a broader range of cancers and human diseases. Juno brings together innovative technologies from some of the world's leading research institutions, including the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, Seattle Children's Research Institute, and The National Cancer Institute. Juno Therapeutics has an exclusive license to the St. Jude Childrens Research Hospital patented technology for CD19 directed product candidates that use 4-1BB, which was developed by Dario Campana, Chihaya Imai, and St. Jude Childrens Research Hospital.
-
Headquarters:400 Dexter Avenue North , Seattle, Washington, United States
More -
Phone Number: +1 206-582-1600
-
Website: https://www.junotherapeutics.com
-
Employees:655
-
Revenue:$500M - 1B
-
Legal Name:Juno Therapeutics, Inc.
-
Juno Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Juno Therapeutics, Inc.
-
Where are Juno Therapeutics, Inc.'s Headquarters?
Juno Therapeutics, Inc.'s Headquarters are in 400 Dexter Avenue North ,Seattle,Washington,United States
-
What is Juno Therapeutics, Inc.'s phone number?
Juno Therapeutics, Inc.'s phone number is +1 206-582-1600
-
What is Juno Therapeutics, Inc.'s official website?
Juno Therapeutics, Inc.'s official website is https://www.junotherapeutics.com
-
What is Juno Therapeutics, Inc.'s Revenue?
Juno Therapeutics, Inc.'s revenue is $500M - 1B
-
What is Juno Therapeutics, Inc.'s NAICS code?
Juno Therapeutics, Inc.'s NAICS code is 325412
-
How many employees are working in Juno Therapeutics, Inc.
Juno Therapeutics, Inc. has 655 employees
-
What is Juno Therapeutics, Inc.'s Industry?
Juno Therapeutics, Inc. is in the industry of Biotechnology
-
Who is Juno Therapeutics, Inc.'s Head Of Project Management Office, Ctdo?
Juno Therapeutics, Inc.'s Head Of Project Management Office, Ctdo is Patricia Anderson